Biogen Inc. (BIIB)

Biogen Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	9,864	9,676	9,836	10,173	10,982	13,445
Revenue Growth (YoY)	2.14%	-1.62%	-3.32%	-7.36%	-18.32%	-6.49%
Cost of Revenue	2,457	2,310	2,533	2,278	2,110	1,805
Gross Profit	7,407	7,366	7,302	7,895	8,872	11,639
Selling, General & Admin	2,425	2,404	2,550	2,404	2,674	2,505
Depreciation & Amortization Expenses	524.2	446.7	240.6	365.9	881.3	464.8
Research & Development	1,924	2,042	2,462	2,231	2,519	4,066
Other Operating Expenses	356.7	223.7	437.6	-589.1	-43.5	54.1
Total Operating Expenses	5,230	5,116	5,690	4,412	6,031	7,089
Operating Income	2,178	2,250	1,612	3,484	2,841	4,550
Other Non-Operating Income (Expense)	-	343.6	315.5	-108.2	0	-497.4
Total Non-Operating Income (Expense)	-	343.6	315.5	-108.2	-	-497.4
Pretax Income	1,798	1,906	1,297	3,592	1,745	5,048
Provision for Income Taxes	267.2	273.8	135.3	632.8	52.5	992.3
Net Income	1,531	1,632	1,161	3,050	1,591	4,006
Minority Interest in Earnings	-	-	0.4	-87.9	136.6	54.6
Net Income to Common	1,531	1,632	1,161	3,050	1,591	4,006
Net Income Growth	32.21%	40.57%	-61.92%	91.67%	-60.28%	-31.04%
Shares Outstanding (Basic)	146	146	145	145	149	161
Shares Outstanding (Diluted)	146	146	146	146	150	161
Shares Change (YoY)	0.45%	0.21%	-0.27%	-2.41%	-7.25%	-13.93%
EPS (Basic)	10.47	11.21	8.02	20.96	10.44	24.86
EPS (Diluted)	10.45	11.18	7.97	20.87	10.40	24.80
EPS Growth	31.61%	40.28%	-61.81%	100.67%	-58.06%	-21.07%
Free Cash Flow	1,979	2,722	1,270	1,144	3,382	3,805
Free Cash Flow Growth	-27.30%	114.28%	11.03%	-66.17%	-11.12%	-42.03%
Free Cash Flow Per Share	13.53	18.66	8.72	7.84	22.61	23.59
Gross Margin	75.10%	76.12%	74.24%	77.61%	80.79%	86.57%
Operating Margin	22.08%	23.25%	16.39%	34.24%	25.87%	33.84%
Profit Margin	15.52%	16.87%	11.81%	29.11%	15.73%	30.20%
FCF Margin	20.06%	28.13%	12.91%	11.25%	30.79%	28.30%
EBITDA	2,922	2,923	2,107	4,002	3,328	5,007
EBITDA Margin	29.62%	30.21%	21.42%	39.34%	30.31%	37.24%
EBIT	2,178	2,250	1,612	3,484	2,841	4,550
EBIT Margin	22.08%	23.25%	16.39%	34.24%	25.87%	33.84%
Effective Tax Rate	14.86%	14.37%	10.43%	17.62%	3.01%	19.66%

Updated Jul 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q